Literature DB >> 29863241

MiR-519d inhibits prostate cancer cell proliferation, cycle and invasion via targeting NRBP1.

C-Q Yan1, Y-H Lu, S-M Tang, W-X Fan.   

Abstract

OBJECTIVE: To investigate the effects of miR-519d on the proliferation, cycle and invasion of human prostate cancer PC3 cells and its possible molecular mechanism.
MATERIALS AND METHODS: The proliferation, cycle, and invasion of human prostate cancer PC3 cells were detected via cell counting kit-8 (CCK-8) and transwell assay. The expression of NRBP1 mRNA was detected via reverse transcription-polymerase chain reaction (RT-PCR). Western blotting was used to detect the expression of NRBP1, cyclin D1, and epithelial-mesenchymal transition (EMT) markers.
RESULTS: The expression of miR-519d in prostate cancer was decreased, which was correlated with tumor size, metastasis, and staging. Proliferation, cycle, and invasion of PC3 cells were significantly decreased after overexpression of miR-519d. Bioinformatics analysis and Western blotting showed that there was a potential miR-519d binding site in NRBP1 3'-UTR, and overexpression of miR-519d significantly inhibited the expression of NRBP1. The expression of E-cadherin in PC3 cells overexpressing miR-519d was up-regulated, and the expressions of N-cadherin, cyclin D1, vimentin, fibronectin, and Snail were down-regulated.
CONCLUSIONS: MiR-519d can repress the proliferation, cycle, and invasion of prostate cancer PC3 cells by inhibiting NRBP1.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29863241     DOI: 10.26355/eurrev_201805_15054

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  4 in total

1.  Down-regulation of lncRNA BLACAT1 inhibits ovarian cancer progression by suppressing the Wnt/β-catenin signaling pathway via regulating miR-519d-3p.

Authors:  Hua Yang; Yue Qi; Xin-Lu Wang; Jiao-Jiao Gu; Tie-Mei Shi
Journal:  Mol Cell Biochem       Date:  2020-02-24       Impact factor: 3.396

2.  High NRBP1 expression promotes proliferation and correlates with poor prognosis in bladder cancer.

Authors:  Qi Wu; Xiaoqing Zhou; Peng Li; Wei Wang; Jun Wang; Mingyue Tan; Le Tao; Jianxin Qiu
Journal:  J Cancer       Date:  2019-07-10       Impact factor: 4.207

3.  MiR-519d targets HER3 and can be used as a potential serum biomarker for non-small cell lung cancer.

Authors:  Aili Wang; Hongxia Zhang; Jinxiang Wang; Shuming Zhang; Zhenyang Xu
Journal:  Aging (Albany NY)       Date:  2020-03-13       Impact factor: 5.682

4.  CircLRP6 contributes to prostate cancer growth and metastasis by binding to miR-330-5p to up-regulate NRBP1.

Authors:  Linghui Qin; Xiaosong Sun; Fei Zhou; Cheng Liu
Journal:  World J Surg Oncol       Date:  2021-06-22       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.